The establishment of Peptonic Medical Inc. is a strategic move aimed at strengthening the Company’s presence in the US market. By creating a dedicated subsidiary with a sole focus on direct sales under Peptonic’s own brand, the Company aims to promote a more clear and effective connection between its Nordic parent company and the US market.

At the same time, Peptonic will continue to operate through its existing US subsidiary, Common Sense Marketing Inc. (CSM), which manages products sold under white label through collaborations with strategic partners.

For more information contact:

Anna Linton, CEO Peptonic Medical AB
Email: anna.linton@peptonicmedical.se
Phone: +46 70-244 92 07

About PEPTONIC medical AB

PEPTONIC medical AB (publ) is a pioneering Swedish medtech company specializing in the development and sale of clinically proven self-care products for women's intimate health. Through its brands VagiVital and Vernivia, the Company offers a broad over-the-counter portfolio of effective and gentle products designed to help women understand, treat, and prevent common medical conditions in the intimate area. Peptonic's growth strategy centers on geographic expansion, particularly in the U.S. and Europe, while continually enhancing its product portfolio through in-house development and strategic acquisitions.

The Company is headquartered in Stockholm, Sweden, and operates a subsidiary, Common Sense Marketing Inc., in the U.S. Peptonic Medical was founded in 2009 and has been listed on the Spotlight Stock Market since 2014.